Screening for PPCM Using AI

Overview

About this study

The overall goal of this study is to investigate the use of artificial intelligence (AI) techniques as a screening tool for cardiomyopathies in pregnancy and the post-partum period.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Women of reproductive age, 18 – 49 years.
  • Seen for clinical care by an obstetrician/gynecologist or cardiologist; advanced practice nurse or physician assistant working in the selected practice.

Exclusion Criteria:  

  • Complex congenital heart disease (single ventricle physiology, complex cardiac surgery or significant shunts with cardiac structural changes).
  • Significant conduction abnormalities.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Demilade Adedinsewo, M.B., Ch.B., M.P.H.

Open for enrollment

Contact information:

Erika Douglass M.P.H.

(904) 953-6595

Douglass.Erika@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Peter Noseworthy, M.D.

Contact us for the latest status

Contact information:

Erika Douglass M.P.H.

(904) 953-6595

Douglass.Erika@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20518325

Mayo Clinic Footer